Age-Related Macular Degeneration Market to Reach $15.4 Billion, Globally, by 2032 at 5.0% CAGR: Allied Market Research

Download Sample Copy- https://www.alliedmarketresearch.com/request-sample/3538  Download Sample Copy-  https://www.alliedmarketresearch.com/request-sample/3538  Prime determinants of growth  The rising number of elderly individuals is a significant factor contributing to the growth of the age-related macular degeneration (AMD) market. With age, the likelihood of developing AMD substantially increases. This expanding elderly population represents a larger customer base for...

Download Sample Copy- https://www.alliedmarketresearch.com/request-sample/3538 

Prime determinants of growth 

The rising number of elderly individuals is a significant factor contributing to the growth of the age-related macular degeneration (AMD) market. With age, the likelihood of developing AMD substantially increases. This expanding elderly population represents a larger customer base for treatments associated with AMD, thereby fueling market growth. Nevertheless, the market's progress may face obstacles due to the high cost associated with AMD medications in the future. On a positive note, the emergence of numerous pipeline drugs offers promising prospects for the coming years.

Report coverage & details: 

 

Covid-19 Scenario 

Procure Complete Report at 20% Discount (251 Pages PDF with Insights, Charts, Tables, and Figures) https://www.alliedmarketresearch.com/checkout-final/age-related-macular-degeneration-AMD-market

The aflibercept segment to maintain its leadership status throughout the forecast period 

Based on drug type, the aflibercept segment held the highest market share in 2022, accounting for more than two-thirds of the global age-related macular degeneration (AMD) market revenue. owing to the rise in the adoption of aflibercept drugs for the treatment of age-related macular degeneration (AMD) across the world. However, the other segment is expected to register the highest CAGR of 7.6% from 2023 to 2032, due to the reason that brolucizumab, verteporfin, and pegcetacoplan are increasingly being prescribed for the treatment of age-related macular degeneration (AMD). 

The wet AMD segment to maintain its leadership status throughout the forecast period 

Based on disease type, the wet AMD segment held the highest market share in 2022, accounting for more than 90% of the global age-related macular degeneration (AMD) market revenue, owing to a rise in the prevalence of wet age-related macular degeneration (AMD) among the elderly population and expensive treatment of wet age-related macular degeneration. However, the dry AMD segment is projected to manifest the highest CAGR of 7.1% from 2023 to 2032. 

The hospital pharmacy segment to maintain its lead position during the forecast period 

Based on distribution channel, the hospital pharmacy segment accounted for the largest share in 2022, contributing to nearly three-fifths of the global age-related macular degeneration (AMD) market revenue, and is projected to maintain its lead position during the forecast period. This is attributed to the increase in sales of prescription age-related macular degeneration (AMD) drugs from hospital pharmacy. The same segment is also expected to cite the fastest CAGR of 5.5% during the forecast period.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/3538 

North America to maintain its dominance by 2031 

Based on region, North America held the highest market share in terms of revenue in 2022, accounting for more than half of the global age-related macular degeneration (AMD) market revenue, which is attributed to the surge in the geriatric population that are vulnerable to age -elated macular degeneration (AMD), presence of key players, and availability of high-quality healthcare system & modern medical technologies. However, the Asia-Pacific region is expected to witness the fastest CAGR of 6.6% from 2023 to 2032. This is owing to the presence of large patient population, growth in awareness for age-related macular degeneration (AMD) drugs, and an increase in public–private investments for unmet medical needs. 

Leading Market Players: - 

The report provides a detailed analysis of these key players in the global age-related macular degeneration marker. These players have adopted new product launches as strategy to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

Trending Reports in Healthcare Industry (Buy Now with 20% Discount):

Surgical Drains Market by Product (Open surgical drainage system, Closed surgical drainage system), by Application (General Surgery, Cardiac & Thoracic Surgery, Orthopedic Surgery, Obstetric/Gynecological Surgery, Other Surgeries), by Type (Active Drains, Passive Drains), by End User (Hospitals, Ambulatory surgery centers (ASCs) & clinics): Global Opportunity Analysis and Industry Forecast, 2020-2030

Digestive Enzymes Market by Origin (Animal, Microbial, Plant), by Enzyme Type (Carbohydrase, Protease, Lipase, Other Enzyme Types), by Applications (Prescription Medicine, Sports Nutrition, Infant Nutrition): Global Opportunity Analysis and Industry Forecast, 2021-2031

Cancer Stem Cells Market by Cancer Forms (Breast, Blood, Lung, Brain, Colorectal, Pancreatic, Bladder, Liver, Others), by Application (Trageted Cancerous Stem Cells, Stem Cell-based cancer Therapy): Global Opportunity Analysis and Industry Forecast, 2021-2031

Animal Model Market by Animal Type (Rat, Mice, Guinea Pigs, Rabbits, and Others), Application (Drug Discovery & Development, Basic Research, and Others), and End User (Pharma & Biotech Companies, Academic Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

Leukapheresis Market by Product (Devices, Disposables), by Method (Centrifugation, Membrane Separation, Selective Adsorption), by Application (Therapeutic Applications, Research Applications), by End User (Blood Centers, Hospitals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Logo: https://mma.prnewswire.com/media/636519/3950895/Allied_Market_Research_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/age-related-macular-degeneration-market-to-reach-15-4-billion-globally-by-2032-at-5-0-cagr-allied-market-research-301854257.html